SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    Jeffrey R Strawn, Caleb M Adler, Robert K McNamara, Jeffrey A Welge, Samantha M Bitter, Neil P Mills, Drew H Barzman, Michael A Cerullo, Kiki D Chang, Stephen M Strakowski, Melissa P DelBello, Antidepressant tolerability in anxious and depressed youth at high risk for bipolar disorder: a prospective naturalistic treatment study, Bipolar Disorders, 2014, 16, 2
  2. 2
    Dongfeng Ma, Zhijun Zhang, Xiangrong Zhang, Lingjiang Li, Comparative efficacy, acceptability, and safety of medicinal, cognitive-behavioral therapy, and placebo treatments for acute major depressive disorder in children and adolescents: a multiple-treatments meta-analysis, Current Medical Research and Opinion, 2014, 1

    CrossRef

  3. 3
    Xin Wu, Fang Liu, Hui Cai, Lin Huang, Yu Li, Zhijiang Mo, Jingwei Lin, Cognitive Behaviour Therapy Combined Fluoxetine Treatment Superior to Cognitive Behaviour Therapy Alone for School Refusal, International Journal of Pharmacology, 2013, 9, 3, 197

    CrossRef

  4. 4
    Robert L. Findling, Adelaide Robb, Anjana Bose, Escitalopram in the Treatment of Adolescent Depression: A Randomized, Double-Blind, Placebo-Controlled Extension Trial, Journal of Child and Adolescent Psychopharmacology, 2013, 23, 7, 468

    CrossRef

  5. 5
    Ae-Jin Goo, Eun-Kyung Won, Cheolsoon Lee, Jong-Il Lee, Hee-Yeon Jung, Yeni Kim, Long-Term Tolerability of Escitalopram in Korean Adolescents, Journal of Korean Academy of Child and Adolescent Psychiatry, 2013, 24, 4, 207

    CrossRef

  6. 6
    David R. Camenisch, Robert J. Hilt, SSRIs for Anxiety and Depression in Children and Adolescents, Psychiatric Annals, 2013, 43, 3, 112

    CrossRef

  7. 7
    David R. Camenisch, Robert J. Hilt, SSRIs for Anxiety and Depression in Children and Adolescents, Pediatric Annals, 2013, 42, 4, 62

    CrossRef

  8. 8
    Fadi T. Maalouf, David A. Brent, Child and Adolescent Depression Intervention Overview: What Works, for Whom and How Well?, Child and Adolescent Psychiatric Clinics of North America, 2012, 21, 2, 299

    CrossRef

  9. 9
    Christine J. Choe, Graham J. Emslie, Taryn L. Mayes, Depression, Child and Adolescent Psychiatric Clinics of North America, 2012, 21, 4, 807

    CrossRef

  10. 10
    A Henry, M D Kisicki, C Varley, Efficacy and safety of antidepressant drug treatment in children and adolescents, Molecular Psychiatry, 2012, 17, 12, 1186

    CrossRef

  11. 11
    Sean Phipps, Kelly E. Buckholdt, Laly Fernandez, Lori Wiener, Mary Jo Kupst, Avi Madan-Swain, Larry Mullins, Rhonda Robert, Olle Jane Sahler, Nicole Vincent, Robert B. Noll, Pediatric oncologists' practices of prescribing selective serotonin reuptake inhibitors (SSRIs) for children and adolescents with cancer: A multi-site study, Pediatric Blood & Cancer, 2012, 58, 2
  12. 12
    Covadonga M. Díaz-Caneja, Ana Espliego, Mara Parellada, Celso Arango, Carmen Moreno, Polypharmacy with antidepressants in children and adolescents, The International Journal of Neuropsychopharmacology, 2012, 1

    CrossRef

  13. 13
    Emily Karanges, Iain S McGregor, Antidepressants and adolescent brain development, Future Neurology, 2011, 6, 6, 783

    CrossRef

  14. 14
    Michelle Goldsmith, Manpreet Singh, Kiki Chang, Antidepressants and Psychostimulants in Pediatric Populations, Pediatric Drugs, 2011, 13, 4, 225

    CrossRef

  15. 15
    Joon-Ho Ahn, Ashwin A Patkar, Escitalopram for the treatment of major depressive disorder in youth, Expert Opinion on Pharmacotherapy, 2011, 12, 14, 2235

    CrossRef

  16. 16
    Susan M. Smiga, Glen R. Elliott, Psychopharmacology of Depression in Children and Adolescents, Pediatric Clinics of North America, 2011, 58, 1, 155

    CrossRef

  17. 17
    Marie Tournier, Brian Greenfield, Guillaume Galbaud du Fort, Thierry Ducruet, Julie Magno Zito, Anne-Marie Cloutier, Yola Moride, Patterns of antidepressant use in Quebec children and adolescents: Trends and predictors, Psychiatry Research, 2010, 179, 1, 57

    CrossRef

  18. 18
    Rongrong Tao, Graham Emslie, Taryn Mayes, Pharmacotherapy for Pediatric Major Depression, Psychiatric Annals, 2010, 40, 4, 192

    CrossRef

  19. 19
    Retraction: Improving Treatment of Adolescent Depression in Primary Care: Clinician Training Enhancements for Nonmental Health Providers and Lessons Learned From Anticipatory Guidance and Treatment Adherence Interventions, Journal of Child and Adolescent Psychiatric Nursing, 2010, no

    CrossRef

  20. 20
    Paul E. Croarkin, Christopher A. Wall, Shawn M. McClintock, Frank Andrew Kozel, Mustafa M. Husain, Shirlene M. Sampson, The Emerging Role for Repetitive Transcranial Magnetic Stimulation in Optimizing the Treatment of Adolescent Depression, The Journal of ECT, 2010, 26, 4, 323

    CrossRef

  21. 21
    Lisa M. Hooper, The unmet needs of depressed adolescent patients: how race, gender, and age relate to evidence-based depression care in rural areas, Primary Health Care Research & Development, 2010, 11, 04, 339

    CrossRef

  22. 22
    Hans-Christoph Steinhausen, Psychische Störungen Bei Kindern und Jugendlichen, 2010,

    CrossRef

  23. 23
    Megan F Joseph, Eric A Youngstrom, Jair C Soares, Antidepressant-coincident mania in children and adolescents treated with selective serotonin reuptake inhibitors, Future Neurology, 2009, 4, 1, 87

    CrossRef

  24. 24
    Rongrong Tao, Graham Emslie, Taryn Mayes, Paul Nakonezny, Betsy Kennard, Carroll Hughes, Early Prediction of Acute Antidepressant Treatment Response and Remission in Pediatric Major Depressive Disorder, Journal of the American Academy of Child & Adolescent Psychiatry, 2009, 48, 1, 71

    CrossRef

  25. 25
    Betsy D. Kennard, Susan G. Silva, Simon Tonev, Paul Rohde, Jennifer L. Hughes, Benedetto Vitiello, Christopher J. Kratochvil, John F. Curry, Graham J. Emslie, Mark Reinecke, John March, Remission and Recovery in the Treatment for Adolescents With Depression Study (TADS): Acute and Long-Term Outcomes, Journal of the American Academy of Child & Adolescent Psychiatry, 2009, 48, 2, 186

    CrossRef

  26. 26
    Tracy L. Skaer, David A. Sclar, Linda M. Robison, Trends in prescriptions for antidepressant pharmacotherapy among US children and adolescents diagnosed with depression, 1990 through 2001: An assessment of accordance with treatment recommendations from the American Academy of Child and Adolescent Psychiatry, Clinical Therapeutics, 2009, 31, 1478

    CrossRef

  27. 27
    Science and the Media, 2009,

    CrossRef

  28. 28
    Daniel Bailly, Benefits and risks of using antidepressants in children and adolescents, Expert Opinion on Drug Safety, 2008, 7, 1, 9

    CrossRef

  29. 29
    SE Hetrick, S Merry, J McKenzie, P Sindahl, M Proctor, Cochrane review: Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents, Evidence-Based Child Health: A Cochrane Review Journal, 2008, 3, 3
  30. 30
    Betsy D. Kennard, Graham J. Emslie, Taryn L. Mayes, Jeanne Nightingale-Teresi, Paul A. Nakonezny, Jennifer L. Hughes, Jessica M. Jones, Rongrong Tao, Sunita M. Stewart, Robin B. Jarrett, Cognitive-Behavioral Therapy to Prevent Relapse in Pediatric Responders to Pharmacotherapy for Major Depressive Disorder, Journal of the American Academy of Child & Adolescent Psychiatry, 2008, 47, 12, 1395

    CrossRef

  31. 31
    Betsy D. Kennard, Sunita M. Stewart, Jennifer L. Hughes, Robin B. Jarrett, Graham J. Emslie, Developing Cognitive Behavioral Therapy to Prevent Depressive Relapse in Youth, Cognitive and Behavioral Practice, 2008, 15, 4, 387

    CrossRef

  32. 32
    E. M. Tsapakis, F. Soldani, L. Tondo, R. J. Baldessarini, Efficacy of antidepressants in juvenile depression: meta-analysis, The British Journal of Psychiatry, 2008, 193, 1, 10

    CrossRef

  33. 33
    Corinne David-Ferdon, Nadine J. Kaslow, Evidence-Based Psychosocial Treatments for Child and Adolescent Depression, Journal of Clinical Child & Adolescent Psychology, 2008, 37, 1, 62

    CrossRef

  34. 34
    Michael Dudley, Dusan Hadzi-Pavlovic, Doug Andrews, Tania Perich, New-generation antidepressants, suicide and depressed adolescents: how should clinicians respond to changing evidence?, Australian and New Zealand Journal of Psychiatry, 2008, 42, 6, 456

    CrossRef

  35. 35
    Amy H Cheung, Carolyn S Dewa, Anthony J Levitt, Rachel A Zuckerbrot, Pediatric depressive disorders: management priorities in primary care, Current Opinion in Pediatrics, 2008, 20, 5, 551

    CrossRef

  36. 36
    Andrea Milne, Summary of ‘Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents’, Evidence-Based Child Health: A Cochrane Review Journal, 2008, 3, 3
  37. 37
    Mareile Bachmann, Christian Bachmann, Winfried Rief, Fritz Mattejat, Wirksamkeit psychiatrischer und psychotherapeutischer Behandlungen bei psychischen Störungen von Kindern und Jugendlichen, Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, 2008, 36, 5, 309

    CrossRef

  38. 38
    C. Moreno, C. Arango, M. Parellada, D. Shaffer, H. Bird, Antidepressants in child and adolescent depression: where are the bugs?, Acta Psychiatrica Scandinavica, 2007, 115, 3
  39. 39
    Howard C. Blue, Louis C. Sanfilippo, Christopher M. Young, Chapter 7., Journal of College Student Psychotherapy, 2007, 21, 3-4, 149

    CrossRef

  40. 40
    Rongrong Tao, Jarrette K Moore, Taryn L Mayes, Graham J Emslie, Depression in children and adolescents: optimizing treatment, Pediatric Health, 2007, 1, 2, 217

    CrossRef

  41. 41
    Humberto Quintana, Grant J. Butterbaugh, William Purnell, Ann K. Layman, Fluoxetine Monotherapy in Attention-Deficit/Hyperactivity Disorder and Comorbid Non-Bipolar Mood Disorders in Children and Adolescents, Child Psychiatry and Human Development, 2007, 37, 3, 241

    CrossRef

  42. 42
    Practice Parameter for the Assessment and Treatment of Children and Adolescents With Depressive Disorders, Journal of the American Academy of Child & Adolescent Psychiatry, 2007, 46, 11, 1503

    CrossRef

  43. 43
    Khrista Boylan, Soledad Romero, Boris Birmaher, Psychopharmacologic treatment of pediatric major depressive disorder, Psychopharmacology, 2007, 191, 1, 27

    CrossRef

  44. 44
    CARROLL W. HUGHES, GRAHAM J. EMSLIE, M. LYNN CRISMON, KELLY POSNER, BORIS BIRMAHER, NEAL RYAN, PETER JENSEN, JOHN CURRY, BENEDETTO VITIELLO, MOLLY LOPEZ, STEVE P. SHON, STEVEN R. PLISZKA, MADHUKAR H. TRIVEDI, Texas Children's Medication Algorithm Project: Update From Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder, Journal of the American Academy of Child & Adolescent Psychiatry, 2007, 46, 6, 667

    CrossRef

  45. 45
    GRAHAM J. EMSLIE, ROBERT L. FINDLING, PAUL P. YEUNG, NADIA R. KUNZ, YUNFENG LI, Venlafaxine ER for the Treatment of Pediatric Subjects With Depression, Journal of the American Academy of Child & Adolescent Psychiatry, 2007, 46, 4, 479

    CrossRef

  46. 46
    Évelyne Jacqz-Aigrain, Les prescriptions médicamenteuses en psychiatrie de l'enfant et de l'adolescent, 2007,

    CrossRef

  47. 47
    Brad Jackson, Susan Lurie, Adolescent Depression: Challenges and Opportunities, Advances in Pediatrics, 2006, 53, 1, 111

    CrossRef

  48. 48
    Susan L McElroy, Renu Kotwal, Rakesh Kaneria, Paul E Keck, Antidepressants and suicidal behavior in bipolar disorder, Bipolar Disorders, 2006, 8, 5p2
  49. 49
    Susan C Sharp, Jessica A Hellings, Efficacy and Safety of Selective Serotonin Reuptake Inhibitors in the Treatment of Depression in Children and Adolescents, Clinical Drug Investigation, 2006, 26, 5, 247

    CrossRef

  50. 50
    George Capone, Parag Goyal, William Ares, Emily Lannigan, Neurobehavioral disorders in children, adolescents, and young adults with Down syndrome, American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2006, 142C, 3
  51. 51
    José Szapocznik, Barbara Lopez, Guillermo Prado, Seth J. Schwartz, Hilda Pantin, Outpatient drug abuse treatment for Hispanic adolescents, Drug and Alcohol Dependence, 2006, 84, S54

    CrossRef

  52. 52
    GRAHAM J. EMSLIE, KAREN DINEEN WAGNER, STAN KUTCHER, STAN KRULEWICZ, REGAN FONG, DAVID J. CARPENTER, ALAN LIPSCHITZ, ANDREA MACHIN, CHRISTEL WILKINSON, Paroxetine Treatment in Children and Adolescents With Major Depressive Disorder: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial, Journal of the American Academy of Child & Adolescent Psychiatry, 2006, 45, 6, 709

    CrossRef

  53. 53
    Amir Raz, Perspectives on the Efficacy of Antidepressants for Child and Adolescent Depression, PLoS Medicine, 2006, 3, 1, e9

    CrossRef

  54. 54
    Carmen Moreno, Ansley M. Roche, Laurence L. Greenhill, Pharmacotherapy of Child and Adolescent Depression, Child and Adolescent Psychiatric Clinics of North America, 2006, 15, 4, 977

    CrossRef

  55. 55
    Roma A. Vasa, Anthony R. Carlino, Daniel S. Pine, Pharmacotherapy of Depressed Children and Adolescents: Current Issues and Potential Directions, Biological Psychiatry, 2006, 59, 11, 1021

    CrossRef

  56. 56
    Betsy D. Kennard, Graham J. Emslie, Taryn L. Mayes, Jennifer L. Hughes, Relapse and Recurrence in Pediatric Depression, Child and Adolescent Psychiatric Clinics of North America, 2006, 15, 4, 1057

    CrossRef

  57. 57
    Graham J Emslie, Taryn L Mayes, Maryse Ruberu, Continuation and Maintenance Therapy of Early-Onset Major Depressive Disorder, Pediatric Drugs, 2005, 7, 4, 203

    CrossRef

  58. 58
    Jeffrey A. Bridge, Cheryl B. Salary, Boris Birmaher, Akua G. Asare, David A. Brent, The risks and benefits of antidepressant treatment for youth depression, Annals of Medicine, 2005, 37, 6, 404

    CrossRef

  59. 59
    Sarah E Hetrick, Joanne E McKenzie, Georgina R Cox, Magenta B Simmons, Sally N Merry, Newer generation antidepressants for depressive disorders in children and adolescents, The Cochrane Library,
  60. 60
    Heidi R. Bruty, Graham J. Emslie, Paul Croarkin, Novel (Atypical) Antidepressants,
  61. 61
    Sarah E Hetrick, Sally N Merry, Joanne McKenzie, Per Sindahl, Michelle Proctor, Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents, The Cochrane Library,
  62. 62
    J. Magno Zito, D.J. Safer, Satish Valluri, The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Children and Adolescents,